Want to see IN:IKS full AI Analyst Report?
IKS Stock Chart & Stats
₹1760.60
₹69.20(3.93%)
At close: 4:00 PM EDT
₹1760.60
₹69.20(3.93%)
Day’s Range― - ―
52-Week Range₹1,262.35 - ₹1,969.00
Previous CloseN/A
Volume129.61K
Average Volume (3M)10.11K
Market Cap
₹285.35B
Enterprise Value₹228.27B
Total Cash (Recent Filing)₹6.09B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)37.3
Beta0.86
Next Earnings
Oct 29, 2026EPS Estimate
13.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)45.64
Shares Outstanding171,573,170
10 Day Avg. Volume5,472
30 Day Avg. Volume10,108
Financial Highlights & Ratios
PEG Ratio0.65
Price to Book (P/B)7.94
Price to Sales (P/S)6.96
P/FCF Ratio37.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,900.00Price Target Upside7.92% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)51.89
Revenue Forecast (FY)₹48.67B
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Earnings GrowthRevenue expansion combined with substantial earnings growth indicates that IKS is scaling its healthcare services platform while converting growth into profit. This strengthens internal funding capacity and supports continued investment in process delivery and technology over the next several quarters.
Healthy ProfitabilityStrong operating and net margins provide a meaningful buffer against ordinary business variability and demonstrate attractive economics in the current service model. If broadly maintained, this profitability can support reinvestment, resilience, and sustained returns on shareholder capital.
Manageable Current Leverage And Solid ReturnsThe latest balance sheet shows moderate leverage relative to equity, while strong ROE indicates effective use of shareholder capital. This combination gives IKS financial flexibility to support operations and growth without the immediate balance-sheet burden associated with high debt.
Bears Say
Weak Operating Cash-flow RealizationOperating cash flow has converted a smaller share of reported earnings in the last three years, indicating weaker and more volatile cash realization than earlier periods. Persistent conversion pressure could constrain internally funded investment and make earnings quality less dependable.
Historical Leverage VolatilityAlthough current leverage is manageable, the sharp historical swings show that IKS’s capital structure has not been consistently stable. A recurrence of elevated leverage could reduce financial flexibility, increase balance-sheet sensitivity, and compete with growth or shareholder-return priorities.
Margin Volatility Reduces Earnings VisibilityReported margin variability makes it harder to determine how much of recent profitability is structurally repeatable. Lower confidence in normalized margins can complicate planning and raises the risk that future earnings growth will not track the latest strong operating performance.
IKS FAQ
What was Inventurus Knowledge Solutions Limited’s price range in the past 12 months?
Inventurus Knowledge Solutions Limited lowest stock price was ₹1262.35 and its highest was ₹1969.00 in the past 12 months.
What is Inventurus Knowledge Solutions Limited’s market cap?
Inventurus Knowledge Solutions Limited’s market cap is ₹285.35B.
When is Inventurus Knowledge Solutions Limited’s upcoming earnings report date?
Inventurus Knowledge Solutions Limited’s upcoming earnings report date is Oct 29, 2026 which is today.
How were Inventurus Knowledge Solutions Limited’s earnings last quarter?
Inventurus Knowledge Solutions Limited released its earnings results on Aug 05, 2026. The company reported ₹11.4 earnings per share for the quarter, missing the consensus estimate of ₹11.425 by -₹0.025.
Is Inventurus Knowledge Solutions Limited overvalued?
According to Wall Street analysts Inventurus Knowledge Solutions Limited’s price is currently Undervalued.
Does Inventurus Knowledge Solutions Limited pay dividends?
Inventurus Knowledge Solutions Limited does not currently pay dividends.
What is Inventurus Knowledge Solutions Limited’s EPS estimate?
Inventurus Knowledge Solutions Limited’s EPS estimate is 13.32.
How many shares outstanding does Inventurus Knowledge Solutions Limited have?
Inventurus Knowledge Solutions Limited has 171,573,170 shares outstanding.
What happened to Inventurus Knowledge Solutions Limited’s price movement after its last earnings report?
Inventurus Knowledge Solutions Limited reported an EPS of ₹11.4 in its last earnings report, missing expectations of ₹11.425. Following the earnings report the stock price went up 1.585%.
Which hedge fund is a major shareholder of Inventurus Knowledge Solutions Limited?
Currently, no hedge funds are holding shares in IN:IKS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Inventurus Knowledge Solutions Limited
Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform that assists physician businesses in outpatient and inpatient care activities in the United States, Canada, and Australia. The company offers a platform that serves healthcare organizations, including health systems/ integrated delivery networks, academic medical centers, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations, and other outpatient healthcare delivery organizations. Inventurus Knowledge Solutions Limited was incorporated in 2006 and is based in Navi Mumbai, India.
IKS Stock 12 Month Forecast
Average Price Target
₹1,900.00
▲(7.92% Upside)
Technical Analysis
Indegene Limited
―
Jubilant Pharmova Limited
―
Syngene International Ltd.
―
Vimta Labs Limited
―
SAI Life Sciences Ltd.
―